l

The content of this website is intended for healthcare professionals only

Metformin may delay ageing process

Study shows widely used diabetes drug slows ageing by mimicking dieting effect

Mark Gould

Wednesday, 03 April 2013

The widely prescribed type 2 diabetes drug metformin slows down the ageing process by mimicking the effects of dieting, according to a new study.

Following a calorie-restricted diet has been shown to improve health in later life and extend lifespan in several animals, from the simple worm to rhesus monkeys.

Researchers writing in the journal 'Cell' today say that metformin has been found to have similar effects in animals, but until now it was not clear exactly how the drug delays the ageing process.

They looked at the effects of metformin on C. elegans worms grown in the presence of E. coli bacteria, a relationship similar to that humans have with the 'healthy' bacteria in our gut. And they found that the worms treated with metformin lived longer only when the E. coli strain they were cultured with was sensitive to the drug.

The team used strains of E. coli with defects in genes that are linked to metabolism and tweaked the levels of nutrients available to tease out which metabolic pathways might be affected by the drug. They found that treatment with metformin disrupted the bacteria's ability to metabolise folate, a type of B-vitamin, and methionine, one of the building blocks of proteins. This limits the nutrients that are available to the worm and mimics the effects of dietary restriction to enable the worms to live longer.

When they added an excess of sugar to the diet, however, the team found that the life-extending effects of metformin were cancelled out. As the drug is used as a treatment for diabetes caused by elevated glucose levels in the blood, this finding is particularly relevant for understanding how the drug works in people.

The study was supported by the Wellcome Trust and the Medical Research Council. Dr Filipe Cabreiro from the Institute of Healthy Ageing at University College London, who led the research, explains: "Overall, treatment with metformin adds up to six days of life for the worm, which is equivalent to around a third of its normal lifespan. It seems to work by altering metabolism in the bacteria that live in the worm, which in turn limits the nutrients that are available to the worm host and has a similar effect to restricting the diet."

Bacteria living in the gut have an important role in helping the host organism to digest and extract nutrition from food. Defects in gut bacteria have been linked to metabolic diseases such as obesity, diabetes, inflammatory bowel disease and cancer. It has also been suggested that gut bacteria may have an impact on the ageing process, but this is the first study to suggest a mechanism for how this works.

Professor David Gems, who directed the study, said: "We don't know from this study whether metformin has any effect on human ageing. The more interesting finding is the suggestion that drugs that alter bacteria in the gut could give us a new way of treating or preventing metabolic diseases like obesity and diabetes."

Picture: Confocal image of C. elegans 
C
redit: Dr David Becker, Wellcome Images

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470